Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Polynucleotides encoding anti-glucagon-like peptide 1 receptor (GLP1R) antagonist antibodies

Polynucleotides encoding anti-glucagon-like peptide 1 receptor (GLP1R) antagonist antibodies

US Patent 12421317 · Granted Sep 23, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof2025
Human antibodies to the human glucagon receptor (HGCGR) and methods of use there2025
Methods of treating urea cycle disorders by interfering with glucagon receptor s2024
VEGF traps and mini-traps and methods for treating ocular disorders and cancer2024
Glucagon-like peptide 1 receptor agonists and uses thereof2024
Substrate for a printed wiring board2024
Anti-PDGF-B antibodies and pharmaceutical composition thereof2024
Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)2024
Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)2024
Glucagon-like peptide 1 receptor agonists and uses thereof2023
Methods of treating severe insulin resistance by interfering with glucagon recep2023
Method of treatment with a fusion protein comprising apelin and an anti-APLNR an2023